These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 21219844)
1. [Risk of affective disorder in multiple sclerosis]. Stenager EN; Stage KB; Stenager E Ugeskr Laeger; 2011 Jan; 173(2):123-6. PubMed ID: 21219844 [TBL] [Abstract][Full Text] [Related]
2. Systematic review of depression in patients with multiple sclerosis and its relationship to interferonβ treatment. Alba Palé L; León Caballero J; Samsó Buxareu B; Salgado Serrano P; Pérez Solà V Mult Scler Relat Disord; 2017 Oct; 17():138-143. PubMed ID: 29055445 [TBL] [Abstract][Full Text] [Related]
4. Psychotic depression: a peculiar presentation for multiple sclerosis. Agan K; Gunal DI; Afsar N; Tuncer N; Kuscu K Int J Neurosci; 2009; 119(11):2124-30. PubMed ID: 19863266 [TBL] [Abstract][Full Text] [Related]
5. [Multiple sclerosis and major depression resistant to treatment. Case of a patient with antidepressive therapy-induced mood disorder, associated with manic features]. Pariante CM; Orrù MG; Carpiniello B; Rudas N Clin Ter; 1995; 146(6-7):449-52. PubMed ID: 7586996 [TBL] [Abstract][Full Text] [Related]
6. Psychiatric side effects of interferon-beta in multiple sclerosis. Goeb JL; Even C; Nicolas G; Gohier B; Dubas F; Garré JB Eur Psychiatry; 2006 Apr; 21(3):186-93. PubMed ID: 16386408 [TBL] [Abstract][Full Text] [Related]
7. Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis. Foley P; Lawler A; Chandran S; Mead G J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):709-10. PubMed ID: 24403283 [No Abstract] [Full Text] [Related]
9. Fluvoxamine treatment of major depression associated with multiple sclerosis. Benedetti F; Campori E; Colombo C; Smeraldi E J Neuropsychiatry Clin Neurosci; 2004; 16(3):364-6. PubMed ID: 15377746 [TBL] [Abstract][Full Text] [Related]
10. Interferon β-induced acute pancreatitis: About two cases with literature review. Aouinti I; Hamza I; Charfi O; Lakhoua G; El Aidli S; Daghfous R; Zaiem A; Kastalli S Therapie; 2019 Jun; 74(3):449-450. PubMed ID: 30665738 [No Abstract] [Full Text] [Related]
11. Interferon beta in multiple sclerosis: how much BENEFIT? Pittock SJ Lancet; 2007 Aug; 370(9585):363-4. PubMed ID: 17678997 [No Abstract] [Full Text] [Related]
12. [Panic and depression: early diagnosis of patients at risk, early treatment with an SSRI (Selective Serotonin Reuptake Inhibitor)]. Psychiatr Prax; 1997 Sep; 24(5 Suppl):1-4. PubMed ID: 9361703 [No Abstract] [Full Text] [Related]
13. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients. Simone IL; Ceccarelli A; Tortorella C; Bellacosa A; Pellegrini F; Plasmati I; De Caro MF; Lopez M; Girolamo F; Livrea P Health Qual Life Outcomes; 2006 Dec; 4():96. PubMed ID: 17163989 [TBL] [Abstract][Full Text] [Related]
14. [A man with erythematosquamous plaques]. Weng YC; Bruynzeel F Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651510 [TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type. Nikfar S; Rahimi R; Abdollahi M Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482 [TBL] [Abstract][Full Text] [Related]
16. Use of interferon-beta in the treatment of multiple sclerosis. Derwenskus J; Lublin FD Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838 [No Abstract] [Full Text] [Related]
17. Multiple sclerosis, interferon beta-1b and depression A prospective investigation. Feinstein A; O'Connor P; Feinstein K J Neurol; 2002 Jul; 249(7):815-20. PubMed ID: 12140662 [TBL] [Abstract][Full Text] [Related]